This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (52)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Ophthalmology, Other  • Articles for Residents  • Alert me on articles by topic  Social Bookmarking   What's this?

Raymond R. Margherio, MD; Alan R. Margherio, MD; George A. Williams, MD; David R. Chow, MD; Michael J. Banach, MD

Arch Ophthalmol. 2000;118:495-498.

Objective  To evaluate the efficacy of perifoveal tissue dissection (PTD) on patients undergoing pars plana vitrectomy for idiopathic macular holes of less than 1-year's duration.

Methods  Pars plana core vitrectomy was performed on 107 eyes of 104 consecutive patients with acute idiopathic macular holes. One cohort had routine PTD. In the other cohort, no attempt was made to strip preretinal tissue. Follow-up was longer than 6 months (follow-up range, 6 to 36 months).

Results  Overall, 95 (89%) of all macular holes were closed. Visual acuity improved 2 lines or more of the Snellen letter chart in 91 eyes (85%). A postoperative visual acuity of 20/50 or better was achieved in 79 eyes (74%). A transient increase in intraocular pressure (30 mm Hg) developed in 25 eyes (23.4%). In 6 eyes (5.6%) a retinal detachment developed. One eye had retinal pigment epithelial changes and 1 patient reported peripheral field loss. No statistically significant differences were noted between eyes having PTD and those without PTD for any outcome measure.

Conclusion  In this series, no beneficial or adverse effect could be demonstrated by performing PTD in eyes undergoing pars plana core vitrectomy for acute idiopathic macular holes.

From the Associated Retinal Consultants and William Beaumont Hospital, Royal Oak, Mich (Drs R. R. Margherio and Williams); Eye Research Institute, Oakland University, Rochester, Mich (Drs R. R. Margherio and Williams); Associated Retinal Consultants PC and Butterworth Hospital, Grand Rapids, Mich (Dr A. R. Margherio); Michigan State University College of Human Medicine, Lansing (Dr A. R. Margherio); and the Beaumont Eye Institute, Royal Oak, Mich, and Oakland University, Eye Research Institute, Rochester, Mich (Drs Chow and Banach).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2000;118(4):597.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

To peel or not to peel the internal limiting membrane: a question finally answered?
Wong
Br J Ophthalmol 2009;93:987-988.
FULL TEXT  

Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial
Christensen et al.
Br J Ophthalmol 2009;93:1005-1015.
ABSTRACT | FULL TEXT  

Relationship between macular hole size and the potential benefit of internal limiting membrane peeling.
Williams
Br J Ophthalmol 2006;90:1216-1217.
FULL TEXT  

Reduction of Indocyanine Green-Associated Photosensitizing Toxicity in Retinal Pigment Epithelium by Sodium Elimination
Ho et al.
Arch Ophthalmol 2004;122:871-878.
ABSTRACT | FULL TEXT  

Surgery for Idiopathic Full-Thickness Macular Hole: Two-Year Results of a Randomized Clinical Trial Comparing Natural History, Vitrectomy, and Vitrectomy Plus Autologous Serum: Moorfields Macular Hole Study Group Report No. 1
Ezra and Gregor
Arch Ophthalmol 2004;122:224-236.
ABSTRACT | FULL TEXT  

Cytotoxicity of Indocyanine Green on Retinal Pigment Epithelium: Implications for Macular Hole Surgery
Ho et al.
Arch Ophthalmol 2003;121:1423-1429.
ABSTRACT | FULL TEXT  

Macular hole size as a prognostic factor in macular hole surgery
Ullrich et al.
Br J Ophthalmol 2002;86:390-393.
ABSTRACT | FULL TEXT